The discriminative stimulus effects of i.v. nicotine in rhesus monkeys: Pharmacokinetics and apparent pA2 analysis with dihydro-β-erythroidine

被引:6
|
作者
Moerke, Megan J. [1 ]
Zhu, Andy Z. X. [2 ]
Tyndale, Rachel F. [2 ]
Javors, Martin A. [3 ]
McMahon, Lance R. [1 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA
[2] Univ Toronto, Campbell Family Mental Hlth Res Inst, CAMH, Dept Pharmacol & Toxicol & Psychiat, Toronto, ON, Canada
[3] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA
基金
美国国家卫生研究院;
关键词
Nicotine; Rhesus monkey; Drug discrimination; Varenicline; Schild analysis; ACETYLCHOLINE-RECEPTORS; VARENICLINE; ANTAGONISM; DETERMINANTS; SENSITIVITY; METABOLISM; SUBUNITS; AGONISTS; SMOKING;
D O I
10.1016/j.neuropharm.2016.12.003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Quantitative analysis of antagonism is infrequently used to identify nAChRs mediating behavioral effects. Here, nicotine (0.032 mg/kg i.v.) was established as a discriminative stimulus in rhesus monkeys responding under a fixed ratio 5 schedule; pharmacokinetics and underlying nAChR mechanism(s) were examined. When measured up to 4 h in venous blood, the training dose resulted in the following mean pharmacokinetic parameters: nicotine C-max = 71.7 ng/ml, t(1/2) = 116 min, and clearance = 6.25 ml/min/kg; cotinine Cmax = 191 ng/ml; and 30H-cotinine C-max = 63 ng/ml. The ED50 value of nicotine to produce discriminative stimulus effects was 0.013 mg/kg. Epibatidine and varenicline increased drug-lever responding to 97% and 95%, respectively (ED50 values = 0.00015 and 0.031 mg/kg, respectively), whereas cocaine, midazolam, and morphine produced no more than 28% drug-appropriate responding. Mecamylamine and dihydro-beta-erythroidine (DH beta E) dose-dependently attenuated the discriminative stimulus effects of the nicotine training dose, whereas methyllycaconitine (MLA) did not. DHOE (0.1 and 0.32) produced rightward shifts of the nicotine and varenicline dose-response functions; Schild plots fitted through individual data resulted in slopes that were not different from unity; the apparent pA(2) calculated for DHPE did not significantly differ in the presence of nicotine (6.58) or varenicline (6.45). Compared to human cigarette smoking, nicotine blood levels after 0.032 mg/kg nicotine i.v. took a similar time to reach maximal concentration, levels at Cmax were similar to smoking 2-3 cigarettes, while average nicotine levels were comparable to smoking 5-6 cigarettes. Apparent pA(2) analysis with DHI beta E under these conditions is consistent with nicotine and varenicline acting through the same nAChRs to produce discriminative stimulus effects. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:9 / 17
页数:9
相关论文
共 9 条
  • [1] APPARENT PA2 VALUES FOR NALOXONE ANTAGONISM OF DISCRIMINATIVE STIMULUS EFFECTS OF NARCOTIC ANALGESICS
    KRIMMER, EC
    BARRY, H
    [J]. FEDERATION PROCEEDINGS, 1977, 36 (03) : 964 - 964
  • [2] Discriminative Stimulus Effects of 1-(2,5-Dimethoxy-4-Methylphenyl)-2-Aminopropane in Rhesus Monkeys: Antagonism and Apparent pA2 Analyses
    Li, Jun-Xu
    Rice, Kenner C.
    France, Charles P.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 328 (03): : 976 - 981
  • [3] Apparent pA2 analysis of 5-HT2A receptor antagonists in rhesus monkeys discriminating DOM
    Li, Jun-Xu
    Rice, Kenner C.
    France, Charles P.
    [J]. FASEB JOURNAL, 2008, 22
  • [4] MU-RECEPTOR-MEDIATED AND KAPPA-RECEPTOR-MEDIATED OPIOID DISCRIMINATIVE EFFECTS IN RHESUS-MONKEYS - PA2 ANALYSIS
    BERTALMIO, AJ
    WINGER, GD
    WOODS, JH
    [J]. FEDERATION PROCEEDINGS, 1984, 43 (04) : 966 - 966
  • [5] Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys
    Ko, MC
    Butelman, ER
    Traynor, JR
    Woods, JH
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 285 (02): : 518 - 526
  • [6] APPARENT PA2 ANALYSIS ON THE RESPIRATORY DEPRESSANT EFFECTS OF ALFENTANIL, ETONITAZENE, ETHYLKETOCYCLAZOCINE (EKC) AND MR2033 IN RHESUS-MONKEYS
    BUTELMAN, ER
    FRANCE, CP
    WOODS, JH
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 264 (01): : 145 - 151
  • [7] Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Δ9- tetrahydrocannabinol
    McMahon, Lance R.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (03): : 1211 - 1218
  • [8] Antagonism of triazolam self-administration in rhesus monkeys responding under a progressive-ratio schedule: In vivo apparent pA2 analysis
    Fischer, Bradford D.
    Platt, Donna M.
    Rallapalli, Sundari K.
    Namjoshi, Ojas A.
    Cook, James M.
    Rowlett, James K.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2016, 158 : 22 - 29
  • [9] IN-VIVO APPARENT PA(2) ANALYSIS FOR NALTREXONE ANTAGONISM OF DISCRIMINATIVE STIMULUS AND ANALGESIC EFFECTS OF OPIATE AGONISTS IN RATS
    WALKER, EA
    MAKHAY, MM
    HOUSE, JD
    YOUNG, AM
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 271 (02): : 959 - 968